Ira Targoff to Lung Diseases, Interstitial
This is a "connection" page, showing publications Ira Targoff has written about Lung Diseases, Interstitial.
Connection Strength
0.869
-
Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007 Apr; 56(4):1295-303.
Score: 0.280
-
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 07; 78(7):988-995.
Score: 0.162
-
Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999 Feb 15; 162(4):2315-20.
Score: 0.160
-
Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review. Scand J Rheumatol. 2018 05; 47(3):210-224.
Score: 0.146
-
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
Score: 0.046
-
Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. J Rheumatol. 2000 Jan; 27(1):161-4.
Score: 0.042
-
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996 Aug; 26(1):459-67.
Score: 0.033